IGF2BP2. In colorectal carcinoma, m6A modification of SOX2 is installed by METTL3 and recognized by IGF2BP2, resulting in upregulated SOX2 that strengthens cell stemness, invasion property, and resistance to oxaliplatin [69]. This evidence concerns the gene SOX2 and colorectal carcinoma.